| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5-day diet to mimic fasting without fasting. FMDs are caloric-restricted plant–based diets containing low proteins, low sugar and high fats which represent a more feasible and safer option to water-only fasting. Fasting modality Approx CRIS -------------------------------------- ---------- Time-restricted eating (12–16 h) –3 to –4 Early time-restricted eating (eTRE) –4 Intermittent fasting (24 h 1–2x/week) –4 Periodic fasting / FMD –4 to –5* Calorie restriction (chronic) –3 (risk tradeoffs) Compare STF(short term Fasting) to FMD IGF-1 / insulin suppression (core driver) | Aspect | STF | FMD | | ----------------- | ------------------- | -------- | | Depth | **Very deep** | Moderate | | Speed | **Rapid (24–48 h)** | Gradual | | Tumor stress | **High** | Medium | | Normal protection | High | High |Fasting-Mimicking Diet (FMD; ~5-day low-protein, low-calorie cycle) Cancer vs Normal Cell Effects
|
| Source: |
| Type: |
| AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways. -Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation. AMPK activators: -metformin or AICAR -Resveratrol: activate AMPK indirectly -Berberine -Quercetin: may stimulate AMPK -EGCG: thought to activate AMPK -Curcumin: may activate AMPK -Ginsenosides: Some ginsenosides have been associated with AMPK activation -Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models. -Alpha-Lipoic Acid (ALA): associated with AMPK activation |
| 1854- | dietFMD, | How Far Are We from Prescribing Fasting as Anticancer Medicine? |
| - | Review, | Var, | NA |
| 1844- | dietFMD, | Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment |
| - | Review, | NA, | NA |
| 1626- | dietSTF, | dietFMD, | When less may be more: calorie restriction and response to cancer therapy |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:79 Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid